females to follow finalist
RISING STAR IN ENTREPRENEURSHIP
Cinzia Silvestri
CEO & Founder
Bi/ond
About Cinzia Silvestri
She is the founder and CEO of Bi/ond, a deep-tech company that strives to provide insightsinto drug efficacy and safety by delivering human-like systems in the lab.Before going "Bi/ond", she did her Ph.D. in microelectronics at the Technical University of Delft. During her academic experience, she realized that her mission was to shorten thedistance between academics and industry.
Leading a diverse and multidisciplinary team of 11 individuals from seven different nationalities, Cinzia has successfully raised €4.8M in both dilutive and non-dilutive financing. Recognized for her achievements, she was named one of the 50 most inspiring women inItaly's technology sector in 2018 and, in 2022, among the top young talents in the Netherlands by Het Financieele Dagblad.Bi/ond, under her visionary leadership, has been included in the Fund Right Initiative for both being a women-led company and for diversity within the team.
For a deeper understanding of Bi/ond's mission and Cinzia's vision, you can watch her TEDx titled: “Your drugs are average”.
About Bi/ond
Bi/ond is a biotechnology start up, established in 2017 as a spin off the prestigious Technical University of Delft (TU Delft). We provide tools to some of the top European hospitals and collaborate with a myriad of technical institutes and research centers to help them advance in their biotech research.
Every person is unique, and our medicines should reflect that as well. The Bi/ond team aims to make this reality of personalized medicine possible by developing a lab technology for more accurate drug testing and simulations of any tissue type.
Through the use of our technology, we also empower organizations with valid alternatives to the use of animals in testing. The possibilities of using tissue slices for culture, and develop 3d perfused models in our organ on chips contribute to the 3Rs guiding principles – replacement, reduction, refinement – of animal use, and a future where an animal free research is more achievable.
Bi/ond is a biotechnology start up, established in 2017 as a spin off the prestigious Technical University of Delft (TU Delft). We provide tools to some of the top European hospitals and collaborate with a myriad of technical institutes and research centers to help them advance in their biotech research.
Every person is unique, and our medicines should reflect that as well. The Bi/ond team aims to make this reality of personalized medicine possible by developing a lab technology for more accurate drug testing and simulations of any tissue type.
Through the use of our technology, we also empower organizations with valid alternatives to the use of animals in testing. The possibilities of using tissue slices for culture, and develop 3d perfused models in our organ on chips contribute to the 3Rs guiding principles – replacement, reduction, refinement – of animal use, and a future where an animal free research is more achievable.
| Powered by: Hyphen Projects BV | Connect with us | Join TOPX | |||
| Privacy Policy Terms & Conditions Chamber of Commerce: 32110979 VAT no: NL8184.34.491.B01 | | |
© Copyright 2020 by Hyphen Projects